3.3 KiB
3.3 KiB
inou Action Items (from App Store Review Analysis)
Generated: 2026-02-09
🔴 Marketing — Use NOW (zero dev work)
- "MyChart shows data. inou explains it." — Landing page positioning against #1 pain point (80+ mentions wanting plain-language explanations)
- "Your genes, actually explained" — Position against 23andMe's vague results + paywall frustration
- "The only imaging app that tells you what it sees" — DICOM viewer positioning
- "Answers, not anxiety" — Target health-anxiety crowd fleeing WebMD/Google
- Compile quote wall — 15+ real user quotes from competitors' reviews expressing desire for exactly what inou does. Devastating social proof.
- "All your health data, one place" — Cross-provider consolidation messaging
🟡 Quick Wins — Low effort, high demand
- Face ID / biometric auth — Universal complaint across every health app. Table stakes.
- JPEG 2000 Lossless DICOM support — Frequent IMAIOS complaint, blocks real users
- Lab trend visualization — Show trends over time with AI commentary ("your cholesterol dropped 15% since March")
- Family health profiles — Parents managing kids' health (MyChart pain point)
🟠 Medium Effort — Clear demand signal
- Side-by-side scan comparison — Multiple DICOM users begging for this. Compare current vs previous MRI.
- Medication tracking + interaction alerts — WebMD/MyChart gap
- Health record export (FHIR/PDF) — Data portability, aligns with "your data stays yours" philosophy
- Comparative lab result context — "Your Vitamin D is 28 — here's what that means, here's the trend, here's what to do"
🔵 Bigger Bets — Differentiation plays
- 3D volume rendering for patients — Requested in DICOM viewers. Would be a killer demo.
- Chronic condition profiles — Ada Health's biggest gap: "remember I have lupus, stop asking if I have a cold"
- Multi-language expansion — Arabic specifically requested (Ada reviews). inou already has 6 languages.
💀 Competitor Vulnerabilities to Exploit
| Competitor | Weakness | inou Angle |
|---|---|---|
| MyChart | Shows data, no explanation | AI explains everything |
| 23andMe | Vague results, paywall, data breach history | Better analysis, no DNA harvesting |
| WebMD | Fear-mongering symptom checker | Calm, contextual AI |
| Ada Health | No medical history context, limited conditions | Full health profile + AI |
| Teladoc | $90 for "take Sudafed" | AI triage before expensive consult |
| 3DICOM | Buggy, crashes, no AI | Reliable + intelligent |
| IMAIOS | No JPEG2000, no side-by-side, no AI | All of the above |
📊 Demand Ranking (by mention volume)
- Plain-language medical explanations (80+) ← inou has this
- UX/navigation that doesn't suck (50+)
- Cross-provider data consolidation (50+) ← inou has this
- Privacy/data ownership (35+) ← inou philosophy
- Affordable access (30+) ← inou free until July
- Genetic result clarity (30+) ← inou has this
- Chronic condition context (25+) ← inou has this
- DICOM viewer that works (25+) ← inou has this
Bottom line: inou already solves 5 of the top 8 pain points. The market is begging for this product. The gap is awareness, not features.